Objective To explore a new method of alleviating graft-versus-host disease(GVHD) after allogeneic bone marrow transplantation(allo-BMT) through selected elimination of mouse alloreactive T cells(ARTC) by Fas-Fas ligand(FasL)passway.
英
美
- 目的 通過(guò)Fas Fas配體 (FasL)途徑清除小鼠同種異體反應性T細胞 (ARTC) ,為減輕異基因骨髓移植 (allo BMT)后的移植物抗宿主病探索新的手段。
